Disease Management

619 articles

Survivor Stories
November 3, 2020 • 6 Min

The Importance of Family and Friends

Michael Florio has been able to count on his family and friends to get him to pancreatic cancer treatment and support him through a Whipple procedure.

Survivor Stories
November 30, 2020 • 4 Min

A Second Opinion Makes the Difference

Irma Infante refused to give up after a stage IV pancreatic cancer diagnosis. She went for a second opinion and better treatment options.

Survivor Stories
January 30, 2019 • 6 Min

Choosing the Strongest Chemotherapy for Pancreatic Cancer

Miriam Hermosa decided to take advantage of her relatively good health and try pancreatic cancer treatment with FOLFIRINOX to get more time with her family.

Page
September 15, 2022 • 1 Min

Leadership

Board of Directors Scientific Advisory Board Advisory Committee Our Team

Member
September 15, 2022 • 2 Min

Mike Greenstein

Mike Greenstein currently serves as the Chair of Let’s Win and is involved in several other not-for-profits where he leverages his financial services and business experience. For many years, Mike served as leader of PwC’s U.S. & Global Alternative Asset Management practice where he helped establish and significantly grow the industry’s leading practice.  Mike is […]

Member
September 15, 2022 • 3 Min

Millicent Fortunoff

Millicent Fortunoff is President of M. Fortunoff Communications. She has extensive experience managing global and national media relations campaigns that build one reputation across regions, yet tailored to local issues and audiences. Prior to opening her own consultancy Ms. Fortunoff was a Senior Vice President in the Global Issues Communications Group at Ruder Finn (Finn […]

Member
September 15, 2022 • 1 Min

Betty Hudson

Betty Hudson is an award-winning communications industry leader with more than four decades of experience in every aspect of corporate and strategic communications, including consumer, employee, financial and cause related marketing, as well as brand and communications management. Having retired as Chief Communications Officer of the National Geographic Society at the end of 2015, Hudson […]

Member
September 15, 2022 • 2 Min

William L. McComb

William L. McComb served as Chief Executive Officer of Liz Claiborne, Inc. (renamed Fifth & Pacific Companies, Inc. in 2012) and was a member of the Company’s Board of Directors from November 6, 2006 to February 25, 2014. He led the Company’s succession in management and name to Kate Spade & Company, after successfully completing […]

Member
September 15, 2022 • 1 Min

Lisa Frame

Any time you read a Facebook post, share a Tweet, or view Instagram from Let’s Win, you are interacting with Lisa Frame. Lisa specializes in digital communications management and strategy. An early adopter of new technology, she was one of the first to use Twitter as a fundraising tool when she served as a colleague […]

Survivor Stories
March 21, 2019 • 5 Min

Long-Term Survival After Grueling Radiation Treatment

Long-term pancreatic cancer survivor Steven Yedwabnick endured a long protocol of radiation and chemotherapy after a Whipple surgery.

Survivor Stories
April 16, 2019 • 4 Min

Climbing the Pancreatic Cancer Mountain

Kenneth Brown got second and third opinions before he chose a treatment plan that included neoadjuvant chemotherapy and a Whipple procedure.

Survivor Stories
July 2, 2019 • 4 Min

No Warning Before My Pancreatic Cancer Diagnosis

Retired wrestling coach Cliff Ramos approached his chemotherapy and Whipple surgery for pancreatic cancer like he was still coaching.

Clinical Trials
April 10, 2018 • 2 Min

Testing a New Drug on Advanced Pancreatic Neuroendocrine Tumors

In a clinical trial, the new drug sapanisertib is being tested for its effectiveness against pancreatic neuroendocrine tumors (PNETs).

Survivor Stories
July 29, 2019 • 4 Min

Surviving Pancreatic Cancer and Embracing Life

Joel Evans’ endocrinologist was concerned so he sent him to get tested for pancreatic cancer. It was caught early enough for a Whipple procedure.

Survivor Stories
November 20, 2019 • 6 Min

Tumor RNA Testing Leads to Treatment with a New Drug

When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.